Heron Therapeuti Stock Probability of Future Stock Price Finishing Over 23.27
| HRTX Stock | USD 1.71 0.05 2.84% |
Heron |
Heron Therapeuti Target Price Odds to finish over 23.27
The tendency of Heron Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 23.27 or more in 90 days |
| 1.71 | 90 days | 23.27 | close to zero percent |
Based on a normal probability distribution, the odds of Heron Therapeuti to move over $ 23.27 or more in 90 days from now is close to zero percent (This Heron Therapeuti probability density function shows the probability of Heron Stock to fall within a particular range of prices over 90 days) . Probability of Heron Therapeuti price to stay between its current price of $ 1.71 and $ 23.27 at the end of the 90-day period is about 48.71 .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.2 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Heron Therapeuti will likely underperform. Additionally Heron Therapeuti has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Heron Therapeuti Price Density |
| Price |
Predictive Modules for Heron Therapeuti
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Heron Therapeuti. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Heron Therapeuti's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Heron Therapeuti Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Heron Therapeuti is not an exception. The market had few large corrections towards the Heron Therapeuti's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Heron Therapeuti, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Heron Therapeuti within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.06 | |
β | Beta against Dow Jones | 2.20 | |
σ | Overall volatility | 0.31 | |
Ir | Information ratio | 0.01 |
Heron Therapeuti Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Heron Therapeuti for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Heron Therapeuti can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Heron Therapeuti had very high historical volatility over the last 90 days | |
| Heron Therapeuti may become a speculative penny stock | |
| Heron Therapeuti has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 127.04 M. Net Loss for the year was (110.56 M) with loss before overhead, payroll, taxes, and interest of (50.51 M). | |
| Heron Therapeuti currently holds about 83.54 M in cash with (58.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.81. | |
| Heron Therapeuti has a frail financial position based on the latest SEC disclosures | |
| Over 82.0% of the company shares are owned by institutional investors | |
| Latest headline from investing.com: Heron Therapeutics wins patent case for CINVANTI drug |
Heron Therapeuti Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Heron Stock often depends not only on the future outlook of the current and potential Heron Therapeuti's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Heron Therapeuti's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 138.1 M | |
| Cash And Short Term Investments | 80.4 M |
Heron Therapeuti Technical Analysis
Heron Therapeuti's future price can be derived by breaking down and analyzing its technical indicators over time. Heron Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Heron Therapeuti. In general, you should focus on analyzing Heron Stock price patterns and their correlations with different microeconomic environments and drivers.
Heron Therapeuti Predictive Forecast Models
Heron Therapeuti's time-series forecasting models is one of many Heron Therapeuti's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Heron Therapeuti's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Heron Therapeuti
Checking the ongoing alerts about Heron Therapeuti for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Heron Therapeuti help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Heron Therapeuti had very high historical volatility over the last 90 days | |
| Heron Therapeuti may become a speculative penny stock | |
| Heron Therapeuti has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 127.04 M. Net Loss for the year was (110.56 M) with loss before overhead, payroll, taxes, and interest of (50.51 M). | |
| Heron Therapeuti currently holds about 83.54 M in cash with (58.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.81. | |
| Heron Therapeuti has a frail financial position based on the latest SEC disclosures | |
| Over 82.0% of the company shares are owned by institutional investors | |
| Latest headline from investing.com: Heron Therapeutics wins patent case for CINVANTI drug |
Additional Tools for Heron Stock Analysis
When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.